What is saffron?

Saffron is the dried stigma of Crocus sativus. As a culinary spice it is famously expensive; as a supplement it is usually sold as a standardised extract. In research, saffron is less about broad longevity promises and more about mood, stress, PMS, and in some cases sleep.

What does the evidence show?

Mood and depressive symptoms

This is where most of the human evidence sits. Several small randomized trials and meta-analyses suggest that saffron can perform better than placebo in mild to moderate depressive symptoms, and in some studies it appeared similar to standard antidepressants.

That sounds impressive, but the limitations matter:

many studies are small
follow-up is usually short
a large share of the literature comes from a limited number of research groups
results do not automatically translate into routine clinical practice

SSRI-induced sexual dysfunction

A surprising finding: in an RCT (Modabbernia 2012, n=36), 30 mg/day of saffron significantly improved sexual function in men suffering from SSRI-induced sexual dysfunction compared to placebo. A separate study in women (Kashani 2013) showed similar results. This is noteworthy because SSRI-induced sexual dysfunction is common and evidence-based solutions are scarce. However, both trials were small.

Stress, anxiety, sleep, PMS

There are also positive signals here, but the evidence base is thinner than for depressive symptoms. That makes saffron more of an interesting candidate than a clearly established multi-purpose supplement.

Is saffron worth it as a supplement?

That is the right question, because saffron is almost always more expensive than simpler alternatives. The current evidence is good enough to call it scientifically interesting — not good enough to claim that the high price is clearly justified on health grounds alone.

Safety

At typical study doses of around 15–30 mg/day, saffron is generally well tolerated. Reported adverse effects are usually mild: gastrointestinal upset, headache, or dry mouth. Extra caution makes sense in:

pregnancy (avoid higher doses)
bipolar disorder
very high-dose products without clear standardisation

Verdict

Saffron is more than expensive-spice marketing — but it is not a clearly proven premium health supplement either. Mood-related outcomes show the most interesting human data. That is still not enough to justify broad health promises or to claim that the price is obviously worth it.

Key Studies

Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials

Hausenblas HA et al. (2013)

Early meta-analysis: saffron outperformed placebo and in small studies appeared comparable to antidepressants in mild to moderate depression.

PubMed PMID 24299602

Effect of saffron on depression, anxiety and mood disorder: a GRADE assessed systematic review and meta-analysis of 34 randomized controlled trials.

Mahmoudi R et al. (2026) n=1,769

BDI -4.39 (95% CI: -6.64 to -2.15), BAI -5.06 (95% CI: -8.44 to -1.68) — but no effect on clinician-rated HDRS/HARS. I² > 90%

Largest meta-analysis (34 RCTs, 1,769 participants): saffron showed significant effects on self-rated questionnaires (BDI: -4.39 points, BAI: -5.06 points) but NO significant effects on clinician-rated scales (HDRS, HARS). Heterogeneity extremely high (I² > 90%). The "self-report positive, clinician-rated negative" pattern suggests placebo effect or reporting bias. GRADE certainty: moderate.

PubMed PMID 41693488

Safety and Efficacy of Saffron (Crocus sativus L.) for Treating Mild to Moderate Depression: A Systematic Review and Meta-analysis

Tóth B et al. (2020)

Saffron was generally well tolerated in included trials and showed advantages over placebo for depressive symptoms.

PubMed PMID 32221179

Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study

Lopresti AL et al. (2021)

Broad overview: mood-related outcomes show the strongest signal; for many other outcomes the evidence is much weaker or still too preliminary.

PubMed PMID 34419735

Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial

Modabbernia A et al. (2012)

RCT (n=36): 30 mg/day saffron significantly improved SSRI-induced sexual dysfunction in men vs placebo (IIEF scores for erection, orgasm, and satisfaction). One of few herbal interventions with positive RCT data for this endpoint.

PubMed PMID 22552758

Saffron (Crocus sativus)